Literature DB >> 1833980

Monoclonal antibody OPD4 is reactive with CD45RO, but differs from UCHL1 by the absence of monocyte reactivity.

S Poppema1, R Lai, L Visser.   

Abstract

Monoclonal antibody OPD4 was described as a novel monoclonal antibody recognizing a helper/inducer T-cell subset in paraffin-tissue sections. The authors have analyzed this reagent with respect to its molecular weight, reactivity with leukocyte common antigen (LCA) transfectants and cell and tissue distribution. OPD4 was found to be reactive with the 180 kd molecular weight isoform of the leukocyte common antigen family, similar to antibody UCHL1 and therefore can be considered as a CD45RO reagent. The only difference in distribution was found to be the absence of OPD4 reactivity with peripheral blood monocytes. Since OPD4 recognizes the same antigen on T cells as UCHL1, both reagents do not need applied in the immunophenotyping of lymphomas.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1833980      PMCID: PMC1886304     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  11 in total

1.  A novel monoclonal antibody (OPD4) recognizing a helper/inducer T cell subset. Its application to paraffin-embedded tissues.

Authors:  T Yoshino; H Mukuzono; H Aoki; K Takahashi; T Takeuchi; I Kubonishi; Y Ohtsuki; M Motoi; T Akagi
Journal:  Am J Pathol       Date:  1989-06       Impact factor: 4.307

2.  Antibody MT3 is reactive with a novel exon B-associated 190-kDa sialic acid-dependent epitope of the leukocyte common antigen complex.

Authors:  S Poppema; R Lai; L Visser
Journal:  J Immunol       Date:  1991-07-01       Impact factor: 5.422

3.  Functional subsets of human helper-inducer cells defined by a new monoclonal antibody, UCHL1.

Authors:  S H Smith; M H Brown; D Rowe; R E Callard; P C Beverley
Journal:  Immunology       Date:  1986-05       Impact factor: 7.397

4.  Monoclonal antibodies (MT1, MT2, MB1, MB2, MB3) reactive with leukocyte subsets in paraffin-embedded tissue sections.

Authors:  S Poppema; H Hollema; L Visser; H Vos
Journal:  Am J Pathol       Date:  1987-06       Impact factor: 4.307

5.  Induction of suppression following autologous mixed lymphocyte reaction; role of a novel 2H4 antigen.

Authors:  T Takeuchi; C E Rudd; S F Schlossman; C Morimoto
Journal:  Eur J Immunol       Date:  1987-01       Impact factor: 5.532

6.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

7.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

8.  Tissue distribution of restricted leukocyte common antigens. A comprehensive study with protein- and carbohydrate-specific CD45R antibodies.

Authors:  R Lai; L Visser; S Poppema
Journal:  Lab Invest       Date:  1991-06       Impact factor: 5.662

9.  Diagnosis of human lymphoma with monoclonal antileukocyte antibodies.

Authors:  R A Warnke; K C Gatter; B Falini; P Hildreth; R E Woolston; K Pulford; J L Cordell; B Cohen; C De Wolf-Peeters; D Y Mason
Journal:  N Engl J Med       Date:  1983-11-24       Impact factor: 91.245

10.  Characterization of CD45 and CD45R monoclonal antibodies using transfected mouse cell lines that express individual human leukocyte common antigens.

Authors:  M Streuli; C Morimoto; M Schrieber; S F Schlossman; H Saito
Journal:  J Immunol       Date:  1988-12-01       Impact factor: 5.422

View more
  9 in total

1.  T lymphocytes expressing HECA-452 epitope are present in cutaneous acute graft-versus-host disease and erythema multiforme, but not in acute graft-versus-host disease in gut organs.

Authors:  R E Davis; B R Smoller
Journal:  Am J Pathol       Date:  1992-09       Impact factor: 4.307

2.  Massive infection and loss of CD4+ T cells occurs in the intestinal tract of neonatal rhesus macaques in acute SIV infection.

Authors:  Xiaolei Wang; Terri Rasmussen; Bapi Pahar; Bhawna Poonia; Xavier Alvarez; Andrew A Lackner; Ronald S Veazey
Journal:  Blood       Date:  2006-10-17       Impact factor: 22.113

3.  Human atherosclerosis. III. Immunocytochemical analysis of the cell composition of lesions of young adults.

Authors:  S Katsuda; H C Boyd; C Fligner; R Ross; A M Gown
Journal:  Am J Pathol       Date:  1992-04       Impact factor: 4.307

4.  Immunologic Profile of Patients Suffering from Herpes Simplex Virus (HSV) -Associated Oral Lesions Treated with Natural Human Interferon Alpha (Egiferon).

Authors:  György Kövesi; Katalin Pálóczi; Klára Ónody; Béla Fekete
Journal:  Pathol Oncol Res       Date:  1997       Impact factor: 3.201

5.  Lymphocytes infiltrating primary cutaneous neoplasms selectively express the cutaneous lymphocyte-associated antigen (CLA).

Authors:  A B Gelb; B R Smoller; R A Warnke; L J Picker
Journal:  Am J Pathol       Date:  1993-05       Impact factor: 4.307

6.  Immunophenotypic and genotypic characterisation of multiple myelomas with adverse prognosis characterised by immunohistological expression of the T cell related antigen CD45RO (UCHL-1).

Authors:  D M Menke; H P Horny; H Griesser; E J Atkinson; E Kaiserling; R A Kyle
Journal:  J Clin Pathol       Date:  1998-06       Impact factor: 3.411

7.  Infiltration of helper/inducer T lymphocytes heralds central nervous system damage in human T-cell leukemia virus infection.

Authors:  Y Iwasaki; Y Ohara; I Kobayashi; S Akizuki
Journal:  Am J Pathol       Date:  1992-05       Impact factor: 4.307

8.  Differential cross-reactivity of monoclonal antibody OPD4 (anti-CD45RO) in macaques.

Authors:  Xiaolei Wang; Bapi Pahar; Terri Rasmussen; Xavier Alvarez; Jason Dufour; Kelsi Rasmussen; Andrew A Lackner; Ronald S Veazey
Journal:  Dev Comp Immunol       Date:  2008-01-28       Impact factor: 3.636

9.  T lymphocytes, CD68-positive cells and vascularisation in thyroid carcinomas.

Authors:  G Herrmann; P M Schumm-Draeger; C Müller; E Atai; B Wenzel; T Fabian; K H Usadel; K Hübner
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.